Profil
Bruce C.
Cooper is President and Chief Executive Officer of CorMedix, Inc. Most recently, he worked at The Medicines Co. and Sanofi-Aventis SA. He is Founder of Delpharm Ltd.
Mr. Cooper has over 18 years of experience in the pharmaceutical industry.
Dr. holds an MD.
Ehemalige bekannte Positionen von Bruce C. Cooper
| Unternehmen | Position | Ende |
|---|---|---|
| CORMEDIX INC. | Direktor/Vorstandsmitglied | 01.11.2009 |
| SANOFI | Corporate Officer/Principal | - |
| THE MEDICINES COMPANY | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANOFI | Health Technology |
| CORMEDIX INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
